Simplex Trading
ABVX

Simplex Trading’s Abivax ABVX Stock Holding History

Simplex Trading’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
1,600
-1,250
-44% -$141K ﹤0.01% 4641
2026
Q1 		$317K Buy
2,850
+1,615
+131% +$191K ﹤0.01% 3766
2025
Q4 		$167K Buy
+1,235
New +$135K ﹤0.01% 4425

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading's ABVX Position: Q2 2026 in Review

Simplex Trading reduced its Abivax (ABVX) stake by 44% in Q2 2026, selling an estimated $141K and leaving 1,600 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #4641.

Simplex Trading first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $317K in Q1 2026. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Simplex Trading held 1,600 shares of Abivax worth $213K as of Q2 2026.
  • Simplex Trading sold 1,250 Abivax shares in Q2 2026, an estimated $141K.
  • Abivax made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4641 holding.
  • Simplex Trading first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Simplex Trading's Abivax position peaked at $317K in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.